Skip to main content
Journal cover image

Rare Genetic Variation and Outcome of Surgery for Mesial Temporal Lobe Epilepsy.

Publication ,  Journal Article
Perucca, P; Stanley, K; Harris, N; McIntosh, AM; Asadi-Pooya, AA; Mikati, MA; Andrade, DM; Dugan, P; Depondt, C; Choi, H; Heinzen, EL ...
Published in: Ann Neurol
December 19, 2022

OBJECTIVE: Genetic factors have long been debated as a cause of failure of surgery for mesial temporal lobe epilepsy (MTLE). We investigated whether rare genetic variation influences seizure outcomes of MTLE surgery. METHODS: We performed an international, multicenter, whole exome sequencing study of patients who underwent surgery for drug-resistant, unilateral MTLE with normal magnetic resonance imaging (MRI) or MRI evidence of hippocampal sclerosis and ≥2-year postsurgical follow-up. Patients with either sustained seizure freedom (favorable outcome) or ongoing uncontrolled seizures since surgery (unfavorable outcome) were included. Exomes of controls without epilepsy were also included. Gene set burden analyses were carried out to identify genes with significant enrichment of rare deleterious variants in patients compared to controls. RESULTS: Nine centers from 3 continents contributed 206 patients operated for drug-resistant unilateral MTLE, of whom 196 (149 with favorable outcome and 47 with unfavorable outcome) were included after stringent quality control. Compared to 8,718 controls, MTLE cases carried a higher burden of ultrarare missense variants in constrained genes that are intolerant to loss-of-function (LoF) variants (odds ratio [OR] = 2.6, 95% confidence interval [CI] = 1.9-3.5, p = 1.3E-09) and in genes encoding voltage-gated cation channels (OR = 2.4, 95% CI = 1.4-3.8, p = 2.7E-04). Proportions of subjects with such variants were comparable between patients with favorable outcome and those with unfavorable outcome, with no significant between-group differences. INTERPRETATION: Rare variation contributes to the genetic architecture of MTLE, but does not appear to have a major role in failure of MTLE surgery. These findings can be incorporated into presurgical decision-making and counseling. ANN NEUROL 2022.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Neurol

DOI

EISSN

1531-8249

Publication Date

December 19, 2022

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Perucca, P., Stanley, K., Harris, N., McIntosh, A. M., Asadi-Pooya, A. A., Mikati, M. A., … EPIGEN Consortium, . (2022). Rare Genetic Variation and Outcome of Surgery for Mesial Temporal Lobe Epilepsy. Ann Neurol. https://doi.org/10.1002/ana.26581
Perucca, Piero, Kate Stanley, Natasha Harris, Anne M. McIntosh, Ali A. Asadi-Pooya, Mohamad A. Mikati, Danielle M. Andrade, et al. “Rare Genetic Variation and Outcome of Surgery for Mesial Temporal Lobe Epilepsy.Ann Neurol, December 19, 2022. https://doi.org/10.1002/ana.26581.
Perucca P, Stanley K, Harris N, McIntosh AM, Asadi-Pooya AA, Mikati MA, et al. Rare Genetic Variation and Outcome of Surgery for Mesial Temporal Lobe Epilepsy. Ann Neurol. 2022 Dec 19;
Perucca, Piero, et al. “Rare Genetic Variation and Outcome of Surgery for Mesial Temporal Lobe Epilepsy.Ann Neurol, Dec. 2022. Pubmed, doi:10.1002/ana.26581.
Perucca P, Stanley K, Harris N, McIntosh AM, Asadi-Pooya AA, Mikati MA, Andrade DM, Dugan P, Depondt C, Choi H, Heinzen EL, Cavalleri GL, Buono RJ, Devinsky O, Sperling MR, Berkovic SF, Delanty N, Goldstein DB, O’Brien TJ, EPIGEN Consortium. Rare Genetic Variation and Outcome of Surgery for Mesial Temporal Lobe Epilepsy. Ann Neurol. 2022 Dec 19;
Journal cover image

Published In

Ann Neurol

DOI

EISSN

1531-8249

Publication Date

December 19, 2022

Location

United States

Related Subject Headings

  • Neurology & Neurosurgery
  • 3209 Neurosciences
  • 3202 Clinical sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences